EPITOPEA
Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, and bioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.
EPITOPEA
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.epitopea.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.3 M GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft DNS
Investors List
Novateur Ventures
Novateur Ventures investment in Seed Round - Epitopea
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Seed Round - Epitopea
Harrington Discovery Institute at University Hospitals
Harrington Discovery Institute at University Hospitals investment in Seed Round - Epitopea
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Seed Round - Epitopea
Advent Life Sciences
Advent Life Sciences investment in Seed Round - Epitopea
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Seed Round - Epitopea
Official Site Inspections
http://www.epitopea.com
- Host name: 104.248.174.66
- IP address: 104.248.174.66
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Epitopea"
About Us - Epitopea
He is an Operating Partner at Advent Life Sciences where he co-founded both Epitopea and the remyelination start-up Pheno Therapeutics, serving both companies as their first CEO. Prior to …See details»
Epitopea - Crunchbase Company Profile & Funding
Organization. Epitopea . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Epitopea is a …See details»
Epitopea Company Profile 2024: Valuation, Funding
Epitopea General Information Description. Developer of transatlantic cancer immunotherapeutics designed to offer to target a novel class of tumor-specific antigens. The company's technology builds on its proprietary and innovative …See details»
Epitopea Announces Leadership Transition and New Appointments
Jul 25, 2024 Dr. Alan C. Rigby, Epitopea’s CEO, said, “It is an honor and I am delighted to be appointed as the new CEO of Epitopea during this pivotal time. Epitopea is at an exciting …See details»
Epitopea - AReNA
Sep 19, 2024 Epitopea is a transatlantic cancer immunotherapy company founded in 2021 between Cambridge (UK), and Montreal (CA). This company originate from Claude Perreault …See details»
CQDM and Epitopea Fund the Development and Validation of …
M ontreal, Quebec, 26 September 2024 – CQDM and Epitopea, a transatlantic cancer immunotherapy company, are proud to announce the launch of a collaborative research …See details»
Epitopea Announces Leadership Transition and New Appointments
Jul 25, 2024 Jon, who has over 20 years’ experience in the pharma and biotech industry, mainly in early-stage discovery and validation, transitions to be Epitopea’s Chief Scientific Officer …See details»
Montréal healthtech startup with transatlantic ties raises $43 …
Oct 25, 2024 Montréal and UK-based startup Epitopea has raised $31 million USD ($43 million CAD) in what it called pre-Series A funding for the research and rollout of their cancer …See details»
Epitopea Closes USD $31 million Pre-Series A Financing
Oct 24, 2024 Proceeds support strategic development and clinical entry of lead Cryptigen immunotherapeutics . CAMBRIDGE, UK and MONTREAL, CANADA, 24 October 2024 – …See details»
Claude Perreault and Pierre Thibault, founders of Epitopea, a …
May 26, 2022 Founded in 2021, the transatlantic biotechnology company Epitopea is the result of collaborations between the teams of Claude Perreault and Pierre Thibault, both principal …See details»
Epitopea - VentureRadar
Epitopea is a pioneering cancer immunotherapeutics company that focuses on developing off-the-shelf RNA-based cancer vaccines. Utilizing its proprietary CryptoMapTM platform, the …See details»
Epitopea - Overview, News & Similar companies | ZoomInfo.com
May 18, 2022 The Newly Founded Company, Epitopea, Has Secured $14 Million in Seed Financing to Advance the Ground-breaking Tumor-Specific Antigen (TSA) Research of Drs. …See details»
Epitopea Announces $14 Million Financing to Advance Cancer ...
Apr 25, 2022 CAMBRIDGE, UK and MONTREAL, CANADA - Epitopea, a transatlantic cancer immunotherapeutics company and global leader in exploiting a new class of untapped tumour …See details»
Epitopea Announces $14 Million Financing to Advance Cancer ...
Apr 25, 2022 Novel Cryptigen TM technology unlocks full potential of Tumour Specific Antigens. CAMBRIDGE, UK and MONTREAL, CANADA, 25 April 2022 - Epitopea, a transatlantic cancer …See details»
Epitopea Announces Leadership Transition and New
Jul 25, 2024 Epitopea is at an exciting crossroad, focused on transitioning from a pre-clinical organization built to robustly ideate and create differentiated immunotherapies to one that is …See details»
Epitopea Announces Leadership Transition and New Appointments
Jul 25, 2024 Dr. Alan C. Rigby, Epitopea’s CEO, said, “It is an honor and I am delighted to be appointed as the new CEO of Epitopea during this pivotal time. Epitopea is at an exciting …See details»
Epitopea secured US$31,000,000 in an epic growth funding round.
Oct 24, 2024 Founded in 2021, Epitopea is led by the visionary CEO Dr. Alan C. Rigby and operates from two significant locations: Cambridge in the United Kingdom and Montreal in …See details»
Epitopea’s $31m pre-Series A is boost for RNA immunotherapies …
Nov 1, 2024 Based in Montreal, Canada, and on Station Road, Cambridge, Epitopea’s proprietary CryptoMap platform is helping to develop accessible off-the-shelf RNA-based …See details»
Careers - Epitopea
At Epitopea, we foster a culture of excellence, collaboration, equality and diversity, offering a comprehensive benefits and lifestyle package. Email us at [email protected] with your CV …See details»